Fitzgibbon James J, Ruan Mengyuan, Heindel Patrick, Appah-Sampong Abena, Dey Tanujit, Khan Ali, Hentschel Dirk M, Ozaki C Keith, Hussain Mohamad A
Division of Vascular and Endovascular Surgery, Department of Surgery, Shapiro Cardiovascular Centre, Brigham and Women's Hospital/Harvard Medical School, 5th Floor, Suite 5-078A, 75 Francis Street, Boston, MA, 02115, USA.
Department of Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.
Sci Rep. 2025 Jun 1;15(1):19203. doi: 10.1038/s41598-025-04310-y.
The goal of this study was to expand our previously created prediction tool (PREDICT-AVF) and web app by estimating long-term primary and secondary patency of radiocephalic AVFs. The data source was 911 patients from PATENCY-1 and PATENCY-2 randomized controlled trials, which enrolled patients undergoing new radiocephalic AVF creation with prospective longitudinal follow up and ultrasound measurements. Models were built using a combination of baseline characteristics and post-operative ultrasound measurements to estimate patency up to 2.5 years. Discrimination performance was assessed, and an interactive web app was created using the most robust model. At 2.5 years, the unadjusted primary and secondary patency (95% CI) was 29% (26-33%) and 68% (65-72%). Models using baseline characteristics generally did not perform as well as those using post-operative ultrasound measurements. Overall, the Cox model (4-6 weeks ultrasound) had the best discrimination performance for primary and secondary patency, with an integrated Brier score of 0.183 (0.167, 0.199) and 0.106 (0.085, 0.126). Expansion of the PREDICT-AVF web app to include prediction of long-term patency can help guide clinicians in developing comprehensive end-stage kidney disease Life-Plans with hemodialysis access patients.
本研究的目的是通过评估头静脉桡动脉内瘘(radiocephalic AVF)的长期初级和次级通畅情况,扩展我们之前创建的预测工具(PREDICT-AVF)和网络应用程序。数据来源是来自PATENCY-1和PATENCY-2随机对照试验的911名患者,这些试验纳入了接受新的头静脉桡动脉内瘘创建手术的患者,并进行前瞻性纵向随访和超声测量。使用基线特征和术后超声测量相结合的方法建立模型,以估计长达2.5年的通畅情况。评估了判别性能,并使用最稳健的模型创建了一个交互式网络应用程序。在2.5年时,未经调整 的初级和次级通畅率(95%CI)分别为29%(26-33%)和68%(65-72%)。使用基线特征的模型通常不如使用术后超声测量的模型表现好。总体而言,Cox模型(4-6周超声)在初级和次级通畅方面具有最佳判别性能,综合Brier评分为0.183(0.167, 0.199)和0.106(0.085, 0.126)。将PREDICT-AVF网络应用程序扩展到包括长期通畅预测,有助于指导临床医生为接受血液透析通路治疗的终末期肾病患者制定全面的生活计划。